Market Cap 49.63M
Revenue (ttm) 22.91M
Net Income (ttm) 1.96M
EPS (ttm) N/A
PE Ratio 20.11
Forward PE N/A
Profit Margin 8.56%
Debt to Equity Ratio 0.00
Volume 2,400
Avg Vol 6,674
Day's Range N/A - N/A
Shares Out 27.42M
Stochastic %K 100%
Beta 0.54
Analysts Strong Buy
Price Target $8.00

Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor a...

Industry: Biotechnology
Sector: Healthcare
Phone: 905 568 8400
Fax: 905 568 5200
Address:
1660 Tech Avenue, Unit 5, Mississauga, Canada
DarkAndyStocktwits
DarkAndyStocktwits Jun. 24 at 10:33 PM
$CVALF I am adding this is a amazing company.
0 · Reply
Biotekman
Biotekman May. 28 at 11:33 AM
$CVALF Q2 results (in CAD).
1 · Reply
Kevn1111
Kevn1111 Feb. 21 at 12:41 PM
$CVALF nice Q4 earnings of .04. Growth still occurring. Floor FV of $3.20. But I think they can do .24 in 2025. At 20x this is $4.80. Company noted headwinds on collagen, but will flip in H2 2025. Let’s see what mkt thinks about this one today.
2 · Reply
Kevn1111
Kevn1111 Jan. 8 at 3:06 PM
$CVALF all my Canadian stocks getting hit lately. Govt unrest and tariffs are noise hurting them.
1 · Reply
ScoutnFinn
ScoutnFinn Jan. 7 at 3:57 PM
$CVALF Agreed. Just added some more. Nice returns. https://www.businesswire.com/news/home/20250107776006/en/Covalon-Announces-Strong-Fourth-Quarter-and-Year-End-Fiscal-2024-Results
0 · Reply
stevhoff
stevhoff Jan. 7 at 12:37 PM
$CVALF Earnings out this AM and they look pretty good. New management has done a great job turning this company around in the last year. I think this one is undervalued.
0 · Reply
Latest News on CVALF
No data available.
DarkAndyStocktwits
DarkAndyStocktwits Jun. 24 at 10:33 PM
$CVALF I am adding this is a amazing company.
0 · Reply
Biotekman
Biotekman May. 28 at 11:33 AM
$CVALF Q2 results (in CAD).
1 · Reply
Kevn1111
Kevn1111 Feb. 21 at 12:41 PM
$CVALF nice Q4 earnings of .04. Growth still occurring. Floor FV of $3.20. But I think they can do .24 in 2025. At 20x this is $4.80. Company noted headwinds on collagen, but will flip in H2 2025. Let’s see what mkt thinks about this one today.
2 · Reply
Kevn1111
Kevn1111 Jan. 8 at 3:06 PM
$CVALF all my Canadian stocks getting hit lately. Govt unrest and tariffs are noise hurting them.
1 · Reply
ScoutnFinn
ScoutnFinn Jan. 7 at 3:57 PM
$CVALF Agreed. Just added some more. Nice returns. https://www.businesswire.com/news/home/20250107776006/en/Covalon-Announces-Strong-Fourth-Quarter-and-Year-End-Fiscal-2024-Results
0 · Reply
stevhoff
stevhoff Jan. 7 at 12:37 PM
$CVALF Earnings out this AM and they look pretty good. New management has done a great job turning this company around in the last year. I think this one is undervalued.
0 · Reply